Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapses”

2,278 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,278 results

Testing effectiveness (Phase 2)UnknownNCT05005468
What this trial is testing

A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC.

Who this might be right for
NSCLC
Shanghai Chest Hospital 61
Not applicableStudy completedNCT07417579
What this trial is testing

Mindfulness and Meditation-Based Relapse Prevention for Substance Use Disorders

Who this might be right for
Substance Use DisordersBehavioral HealthAddiction Psychological+4 more
Bout Me Healing 3
Testing effectiveness (Phase 2)Study completedNCT01259869
What this trial is testing

PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression

Who this might be right for
Glioblastoma
NCIC Clinical Trials Group 34
Large-scale testing (Phase 3)Study completedNCT00546780
What this trial is testing

Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 31
Not applicableStudy completedNCT00001938
What this trial is testing

A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)

Who this might be right for
Ovarian Neoplasm
National Cancer Institute (NCI) 26
Not applicableUnknownNCT00192582
What this trial is testing

AIMHI NT Relapse Prevention Trial

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychoses, Substance Induced+2 more
Menzies School of Health Research 90
Early research (Phase 1)UnknownNCT04861480
What this trial is testing

Dual-target CAR-T Cells (C-4-29) in the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Chongqing Precision Biotech Co., Ltd 18
Not applicableStudy completedNCT03960138
What this trial is testing

Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking

Who this might be right for
Tobacco Use Disorder
University of Missouri-Columbia 63
Large-scale testing (Phase 3)Study completedNCT00662649
What this trial is testing

Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis 920
Not applicableStudy completedNCT02190968
What this trial is testing

Reducing Residual Depressive Symptoms With Web-based Mindful Mood Balance

Who this might be right for
Major Depressive Disorder, Recurrent, in RemissionDepressive Symptoms
University of Toronto 460
Not applicableStudy completedNCT02861820
What this trial is testing

Functional Connectivity Changes During Early Recovery as a Marker for Relapse

Who this might be right for
Substance Use Disorder
University of Minnesota 160
Testing effectiveness (Phase 2)Study completedNCT03436862
What this trial is testing

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

Who this might be right for
Hodgkin Lymphoma
SCRI Development Innovations, LLC 37
Large-scale testing (Phase 3)Study completedNCT00657488
What this trial is testing

Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 400
Large-scale testing (Phase 3)Not Yet RecruitingNCT07189325
What this trial is testing

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)Anti-CD20 Therapy
University Hospital, Montpellier 250
Post-approval studies (Phase 4)UnknownNCT03579082
What this trial is testing

A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Mingzhi Zhang 60
Not applicableStudy completedNCT05169203
What this trial is testing

The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study

Who this might be right for
Diffuse Large B Cell LymphomaDiffuse Large B-Cell Lymphoma Cell of OriginDiffuse Large B-cell Lymphoma Recurrent
Herlev Hospital 2,969
Not applicableStudy completedNCT00538603
What this trial is testing

Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)

Who this might be right for
Epithelial Ovarian Cancer
King Faisal Specialist Hospital & Research Center 8
Post-approval studies (Phase 4)Study completedNCT02032576
What this trial is testing

Predictors of the Response and Relapse/Recurrence After ECT for Depressed Patients

Who this might be right for
Major Depressive Episode
Kaohsiung Kai-Suan Psychiatric Hospital 170
Testing effectiveness (Phase 2)Study completedNCT00489489
What this trial is testing

Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 118
Testing effectiveness (Phase 2)Study completedNCT00129168
What this trial is testing

Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid
Kanisa Pharmaceuticals 100
Load More Results